The global Gene Therapy for Rare Disease Market is estimated to be valued at US$ 193.56 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |